A carregar...
Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)
BACKGROUND: Peptide receptor radionuclide therapy (PRRT) with [(177)Lu]-DOTA-TATE is an effective treatment of neuroendocrine tumors (NETs). After each cycle of treatment, patient dosimetry evaluates the radiation dose to the risk organs, kidneys, and bone marrow, the most radiosensitive tissues. Ab...
Na minha lista:
| Publicado no: | EJNMMI Phys |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006002/ https://ncbi.nlm.nih.gov/pubmed/29916115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-018-0211-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|